Shao Hua, Li Yonghua, Zhao Heng, Lin Ken, Gao Yan, Ming Cheng, Ma Jing
Department of Otorhinolaryngology Head and Neck Surgery,Kunming Children's Hospital(Children's HospitalAffiliated to Kunming Medical University),Kunming,650228,China.
KunmingKey Laboratory for Prevention and Control of CongenitalBirth Defects of Children.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Jul;38(7):636-640. doi: 10.13201/j.issn.2096-7993.2024.07.015.
To investigate the clinical phenotype of a family with branchio-oto syndrome (BOS) and to explore the genetic etiology of the syndrome in this family. Clinical data were collected from a child diagnosed with BOS and his family members. Genomic DNA was extracted from peripheral blood of the proband and his family members. Whole-exome sequencing was performed, and the mutation sites were verified and analyzed by Sanger sequencing. The family consists of two generations with four members, three of whom exhibit the phenotype. Two members have hearing loss and bilateral preauricular fistulas and bilateral branchial cleft fistulas. One member has bilateral preauricular fistulas and bilateral branchial cleft fistulas. All of which were in line with the clinical diagnosis of gill ear syndrome, the inheritance mode of the family was autosomal dominant inheritance, genetic testing showed that all members of the family had c. 1744delC(p. L592Cfs47) mutation in the gene, while unaffected members have the wild-type allele at this locus. This mutation is a frameshift mutation, which results in the early appearance of the stop codon, and has not been reported so far. According to ACMG guidelines, the variant was preliminarily determined to be suspected pathogenic. The newly discovered EYA1c. 1744delC(p. L592Cfs47) mutation in this family is the pathogenic mutant gene of the patients in this family, which further expands the mutation spectrum of gene, gives us a new understanding of the disease, and provides an important reference for clinical diagnosis and genetic counseling.
为研究一个鳃耳综合征(BOS)家系的临床表型,并探索该家系中该综合征的遗传病因。收集了一名被诊断为BOS的患儿及其家庭成员的临床资料。从先证者及其家庭成员的外周血中提取基因组DNA。进行全外显子组测序,并通过桑格测序对突变位点进行验证和分析。该家系由两代四人组成,其中三人表现出该表型。两名成员有听力损失、双侧耳前瘘管和双侧鳃裂瘘管。一名成员有双侧耳前瘘管和双侧鳃裂瘘管。所有这些均符合鳃耳综合征的临床诊断,该家系的遗传方式为常染色体显性遗传,基因检测显示该家系所有成员在该基因中有c. 1744delC(p. L592Cfs47)突变,而未受影响的成员在该位点有野生型等位基因。该突变是一个移码突变,导致提前出现终止密码子,且迄今为止尚未见报道。根据美国医学遗传学与基因组学学会(ACMG)指南,该变异初步判定为疑似致病。这个家系中新发现的EYA1基因c. 1744delC(p. L592Cfs47)突变是该家系患者的致病突变基因,进一步扩展了该基因的突变谱,使我们对该疾病有了新的认识,并为临床诊断和遗传咨询提供了重要参考。